missing translation for 'onlineSavingsMsg'
Learn More
Learn More
MYL9 Monoclonal Antibody (OTI3H6), TrueMAB™, OriGene
Mouse Monoclonal Antibody
Brand: Origene Technologies TA813394
This item is not returnable.
View return policy
Description
MYL9 Monoclonal antibody specifically detects MYL9 in Human, Mouse, Rat samples. It is validated for Western BlotSpecifications
| MYL9 | |
| Monoclonal | |
| 1 mg/mL | |
| PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
| P24844, Q64122, Q9CQ19 | |
| Mouse | |
| Protein A/G | |
| RUO | |
| 10398, 296313, 98932 | |
| -20° C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Western Blot | |
| OTI3H6 | |
| Unconjugated | |
| MYL9 | |
| 20 kDa myosin light chain; AI327049; DTNB; G1; Isoform L20-A; LC20; light polypeptide 9; MGC3505; MLC2; MLC-2; MLC20; MLC-2C; MRLC1; myl9; myl9.L; myl9b; myl9l; Mylc2c; myosin light chain 2; myosin light chain 9; myosin light chain 9 L homeolog; myosin light chain, regulatory C; myosin regulatory light chain; myosin regulatory light chain 1; myosin regulatory light chain 2, smooth muscle isoform; Myosin regulatory light chain 2, smooth muscle major isoform; myosin regulatory light chain 9; Myosin regulatory light chain MRLC1; myosin regulatory light polypeptide 9; myosin regulatory light polypeptide 9b; myosin RLC; myosin, light chain 9, regulatory; myosin, light chain 9b, regulatory; myosin, light polypeptide 9, regulatory; Myrl2; RLC-C; smooth muscle major isoform; unnamed protein product; XELAEV_18003093mg; zgc:77916 | |
| Full length human recombinant protein of human MYL9 (NP_006088) produced in HEK293T cell. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG2b |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction